Mori A, Kaminuma O, Suko M, Mikami T, Nishizaki Y, Ohmura T, Hoshino A, Asakura Y, Miyazawa K, Ando T, Okumura Y, Yamamoto K, Okudaira H
Department of Medicine and Physical Therapy, Faculty of Medicine, University of Tokyo, Japan.
J Allergy Clin Immunol. 1997 Dec;100(6 Pt 2):S56-64. doi: 10.1016/s0091-6749(97)70006-x.
Cytokines produced by helper T cells are intimately involved in chronic allergic diseases associated with eosinophilic inflammation.
We investigated the production of IL-5, a potent growth factor and chemotactic factor for eosinophils, by CD4+ T lymphocytes in patients with asthma.
Allergen-specific T cell clones and T cell hybridomas were established from the peripheral blood lymphocytes of patients with asthma, and the responses to various stimuli were determined.
After nonspecific stimulation, IL-5 production by CD4+ T cells from both atopic and nonatopic subjects with asthma was significantly enhanced compared with that by cells from healthy controls. Peripheral blood mononuclear cells from atopic asthma patients both proliferated and produced IL-5 after incubation with mite allergen, suggesting that mite-specific helper T cells were involved in the eosinophilic inflammation of atopic asthma. A human IL-5 promoter/enhancer luciferase gene construct transfected into IL-5-producing T cell clones was clearly transcribed after stimulation, indicating that the 515 base pair IL-5 gene segment upstream of the coding region was sufficient to respond to activating signals in human helper T cells. The same gene segment was not transcribed in IL-5-nonproducing T cell clones, suggesting that human T cell IL-5 synthesis is regulated at the transcriptional level. Experiments with T cell hybridomas confirmed these findings and suggested that a unique transcription factor may be essential for human IL-5 gene transcription.
Enhanced IL-5 production by helper T cells seems to cause the eosinophilic inflammation of both atopic and nonatopic asthma. Elucidation of IL-5-specific regulatory mechanisms may facilitate the development of novel treatments for allergic diseases associated with eosinophilic inflammation.
辅助性T细胞产生的细胞因子与嗜酸性粒细胞炎症相关的慢性过敏性疾病密切相关。
我们研究了哮喘患者CD4+ T淋巴细胞产生白细胞介素-5(IL-5,一种对嗜酸性粒细胞有强大作用的生长因子和趋化因子)的情况。
从哮喘患者外周血淋巴细胞中建立过敏原特异性T细胞克隆和T细胞杂交瘤,并测定其对各种刺激的反应。
非特异性刺激后,与健康对照者的细胞相比,特应性和非特应性哮喘患者的CD4+ T细胞产生IL-5的能力显著增强。特应性哮喘患者的外周血单个核细胞与螨过敏原孵育后增殖并产生IL-5,提示螨特异性辅助性T细胞参与了特应性哮喘的嗜酸性粒细胞炎症。转染到产生IL-5的T细胞克隆中的人IL-5启动子/增强子荧光素酶基因构建体在刺激后明显转录,表明编码区上游515个碱基对的IL-5基因片段足以响应人辅助性T细胞中的激活信号。相同的基因片段在不产生IL-5的T细胞克隆中不转录,提示人T细胞IL-5的合成在转录水平受到调控。T细胞杂交瘤实验证实了这些发现,并提示一种独特的转录因子可能对人IL-5基因转录至关重要。
辅助性T细胞IL-5产生增加似乎导致了特应性和非特应性哮喘的嗜酸性粒细胞炎症。阐明IL-5特异性调节机制可能有助于开发针对与嗜酸性粒细胞炎症相关的过敏性疾病的新疗法。